Shanhe Pharma: The company successfully passed the on-site inspection by the US FDA.

Shanhe Pharmaceutical Co., Ltd. announced that the company underwent an on-site inspection by the U.S. Food and Drug Administration from December 4, 2025, to December 5, 2025. The inspection scope covered six major systems including quality management, production management, facility and equipment management, laboratory quality control, and material and packaging label management. The company received an on-site inspection report from the U.S. FDA confirming the completion of the inspection, and the company successfully passed the FDA on-site inspection.